Krishna Kittu Kolluri's Net Worth

$565 Million

Estimate Recalculated Mar 1, 2024 05:59PM EST

Who is Krishna Kittu Kolluri?

Krishna Kittu Kolluri has an estimated net worth of $565 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., OPOWER, INC., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Echo Global Logistics, Inc., NETSCREEN TECHNOLOGIES INC, FUSION-IO, INC., ARYx Therapeutics, Inc., PEPLIN INC, TriVascular Technologies, Inc., INNERWORKINGS INC, HYPERION THERAPEUTICS INC, JUNIPER NETWORKS INC, SUPERNUS PHARMACEUTICALS INC, CHANNELADVISOR CORP, Groupon, Inc., AVEO PHARMACEUTICALS INC, Zosano Pharma Corp, Clovis Oncology, Inc., Adaptimmune Therapeutics PLC, AMICUS THERAPEUTICS INC, BOX INC, Loxo Oncology, Inc., Dermira, Inc., CHAMPIONS ONCOLOGY, INC., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., Mirna Therapeutics, Inc., Epizyme, Inc., SUNESIS PHARMACEUTICALS INC, Cerecor Inc., Roka BioScience, Inc., ARCA biopharma, Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., Heliogen, Inc., Tableau Software Inc, CVENT INC, Achaogen Inc, XOOM Corp, AUDIENCE INC, INTERLEUKIN GENETICS INC, and HEMOSENSE INC.

SEC CIK

Krishna Kittu Kolluri's CIK is 0001270521

Past Insider Trading and Trends

2014 was Krishna Kittu Kolluri's most active year for acquiring shares with 63 total transactions. Krishna Kittu Kolluri's most active month to acquire stocks was the month of May. 2014 was Krishna Kittu Kolluri's most active year for disposing of shares, totalling 77 transactions. Krishna Kittu Kolluri's most active month to dispose stocks was the month of July. 2012 saw Krishna Kittu Kolluri paying a total of $47,273,376.30 for 54,282,839 shares, this is the most they've acquired in one year. In 2015 Krishna Kittu Kolluri cashed out on 40,166,745 shares for a total of $109,694,659.41, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AUDIENCE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-757.00
0
Mar 13
Form 4
-49.96%
-1.44M
1.44M
Nov 4
Form 4
-32.71%
-1.40M
2.88M
Feb 15
Form 4
4.28M
4.28M
May 15
Form 3
0
0
No matching records found

SUPERNUS PHARMACEUTICALS INC (SUPN) Snapshot price: $27.36

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-49.79%
-3.81M
3.84M
Nov 11
Form 4
-28.11%
-2.99M
7.65M
Jun 15
Form 4
10.64M
$5.00
10.64M
May 4
Form 3
0
0
No matching records found

HEMOSENSE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

OPOWER, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.99M
$10.30
-$92,594,589.80
0
Jun 14
Form 4
8.99M
8.99M
Apr 9
Form 3
0
0
No matching records found

TriVascular Technologies, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.94M
0
Feb 3
Form 4
3.94M
$12.00
$6,999,996.00
3.94M
Apr 22
Form 3
0
0
No matching records found